Journal of drug assessment Journal

Overview

publication venue for

Real-world experience of ocrelizumab in multiple sclerosis in an Arab population.. 10. 2021
Efficacy and safety of PCSK9 monoclonal antibodies: an evidence-based review and update. 2020

Identity

ISO Abbreviation

J Drug Assess

Linking ISSN

2155-6660

International Standard Serial Number (ISSN)

2155-6660